Compass Pathways
The Director, Commercial Training at Compass Pathways will design and execute a comprehensive commercial training strategy to support the launch and commercialization of COMP360 and future therapies. This role involves developing training content, field readiness programs, and ongoing capability development while collaborating with multiple departments to deliver compliant and high-impact training experiences.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2016
Compass Pathways is a biotechnology company developing psilocybin-based therapies for treatment-resistant depression and other serious mental health conditions. It conducts clinical research and develops treatment models that combine psychedelic compounds with psychological support.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Compass Pathways.
21% above the average for this role
BREAKING: Second Positive Phase 3 for Compass' Psilocybin, Though Modest Magnitude Raises Questions
3 weeks ago
Lead, Disease State Training
AstraZeneca
Lead, Disease State Training
AstraZeneca
Zonal Training Manager
Sun King
Director, Commercial Training & Effectiveness
Mirum Pharmaceuticals
Director, Commercial Training & Sales Enablement
Baxter International
Senior Instructional Designer, Sales & Product Training
C0000160857P